Author: Purple Foxy
New Chief Financial Officer Hire Strengthens AMC Health’s Executive Leadership Team
NEW YORK – November 8, 2022 – (Newswire.com)
AMC Health is pleased to announce the appointment of Mr. Steve Tsamaras, a seasoned financial executive, to the position of Chief Financial Officer. This strategic appointment will strengthen AMC Health’s executive team and follows the announcement made on 19 Oct. 2022 of AMC Health’s collaboration with global leader GE Healthcare.
Mr. Tsamaras brings over 20 years of public and private company experience in a wide range of finance and business functions within various industries. He has a proven track record of, and accountability for, financial control and reporting, accounting, tax, M&A, risk and compliance, and audit, in his prior roles. He is a highly experienced finance leader having held a number of leadership roles and has helped companies maximize profitability, operational efficiencies, and capital market objectives.
“I am delighted that Steve is joining AMC Health and bringing with him his extensive financial services knowledge and experience and a proven track record of leading high-performing businesses,” said Nesim Bildirici, Chief Executive Officer of AMC Health.
Prior to joining AMC Health, Mr. Tsamaras was Chief Accounting Officer for BVI Medical, a private medical device company. Steve has held divisional finance roles with General Electric, Siemens and Liberty Mutual. Steve is an alumnus of KPMG and PricewaterhouseCoopers. He obtained his C.P.A. license in the state of Massachusetts and holds a BS in accountancy from Bentley University.
“I am very excited to be joining AMC Health at this important time in its history and look forward to working with Nesim Bildirici and the executive team in their objective of executing the delivery of the growth strategy.”
About AMC Health:
Founded in 2002, AMC Health’s Virtual Care and Remote Patient Monitoring suite of solutions leverages a superior analytics platform and a simple user interface that integrates easily into clinical workflows. AMC Health’s advanced, real-time, analytics-driven, virtual care solutions have driven outstanding and measurable outcomes to hundreds of thousands of patients across the healthcare continuum, including payers, provider systems and governmental agencies. Its FDA Class II 510(k)-cleared, clinical decision support platform is combined with end-to-end, clinical and support RPM services that enable healthcare organizations to confidently extend their services beyond the four walls of hospital and ambulatory clinic settings. AMC Health’s unparalleled corpus of peer-reviewed, published studies highlight clinical improvements for conditions including heart failure, diabetes, and hypertension, resulting in reductions in hospital admissions and substantial financial returns on investment. For more information, visit www.amchealth.com.
Contact Information:
Mari Mescolotto
Chief Marketing Officer
561-245-0511
Press Release Service
by
Newswire.com
Original Source:
New Chief Financial Officer Hire Strengthens AMC Health’s Executive Leadership Team
Genomic transposable elements modify the progression of Parkinson’s disease
WASHINGTON – November 8, 2022 – (Newswire.com)
A recently published article in Experimental Biology and Medicine (Volume 247, Issue 18, September, 2022) improves our understanding of genomic transposable elements and Parkinson’s disease. The study, led by Dr. Sulev Koks, head of Genetic Epidemiology Research at Perron Institute for Neurological and Translational Science and the Centre for Molecular Medicine and Innovative Therapeutics at Murdoch University (Australia), and Dr. John Quinn, chair of Neurobiology in the department of Pharmacology and Therapeutics at the University of Liverpool (United Kingdom), describes how transposable elements were associated with Parkinson’s subtypes and impact disease trajectory.
Transposable elements make up more than 70% of the human genome, but until recently, they have been considered as ‘junk’ DNA without any meaningful function. These elements have been largely ignored in most genetic studies and could therefore contribute to the currently unknown genetic factors that influence disease development. Prior studies by Koks and colleagues have shown that these elements have a significant regulatory role in the genome. They regulate the expression of many genes, orchestrate complex genetic activation where multiple genes are needed for a complex response, and a growing body of evidence suggests that these elements have a major pathogenetic effect, with several elements shown to cause disease.
This study, led by Dr. Koks, analyzed the variation of transposable elements and their impact on different trajectories of Parkinson’s disease. They used patient data from the Parkinson’s Progression Markers Initiative, and five-year follow-up data from Parkinson’s patients who also had whole genome sequencing data available. This allowed them to develop a comprehensive genomic screen for the transposable elements in these patients. Koks et al found that transposable elements were associated with Parkinson’s subtypes and disease trajectory. Some transposable elements predicted faster progression of the disease, with very fast deterioration of motor or cognitive functions. The effect of transposable elements wasn’t unidirectional. Depending on their type and position in the genome, these elements had a negative or positive effect. Some elements were associated with a strong and clinically meaningful change in functional Parkinson’s scores. At the same time, some transposable elements were protective and associated with a slower disease progression suggesting a slowing of neuronal loss and neurodegeneration.
Dr. Koks said: “Transposable elements are part of the genome which is known as the ‘dark genome.'” He continued: “Our study showed that the dark genome may have a much more significant impact on the pathophysiology of complex disease than previously estimated. The elements inside the dark genome could enhance or slow the progression of Parkinson’s disease and therefore open up new opportunities for precision medicine.” Dr. Quinn added, “Our body of work over a decade highlights the importance of targeting these elements for therapeutic intervention in the progression of neurodegenerative diseases which is the subject of our current work not only in Parkinson’s Disease but also Motor Neurone Disease. This could include repositioning of drugs from other disease areas in which these elements are implicated in disease progression.”
Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said “This fascinating study by Koks and his colleagues demonstrates that the presence or absence of transposable elements controls the progressions trajectory of Parkinson’s Disease. It further underscores the importance of rigorous analysis of these genomic elements is essential for considering therapeutic opportunities.”
Experimental Biology and Medicine is a global journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences. The journal was first established in 1903. Experimental Biology and Medicine is the journal of the Society of Experimental Biology and Medicine. To learn about the benefits of society membership visit www.sebm.org. If you are interested in publishing in the journal, please visit http://ebm.sagepub.com.
For more information, please contact ebm@sebm.org.
Contact Information:
Benjamin Zimmer
Press Release Service
by
Newswire.com
Original Source:
Genomic transposable elements modify the progression of Parkinson’s disease
Signature Healthcare Partners With Clearway Health to Expand Community Access With Retail Pharmacy
In partnership with Clearway Health, Signature Healthcare has opened a convenient new pharmacy location
Signature Healthcare and Clearway Health cu…
Read More
RosmanSearch Introduces Gastroenterology Recruitment Service
Department Logo Company Logo with subbrand heading. Reads: RosmanSearch – Targeted Gastroenterology Recruiting
PEPPER PIKE, Ohio – November 8, 20…
Imagoworks Launches AI-Based Web Dental CAD 3Dme Crown
Reduce prosthesis design time to less than 1 minute with AI technology.
Imagoworks Imagoworks 3Dme Crown
SEOUL, South Korea …
12th Annual National Rural Health Day is November 17
Live virtual event highlights the power of rural stakeholder collaboration
National Rural Health Day Official logo for National Rural Health Day …
Read More
Radiology Patient Action Network Calls on Congress to Stop Deep Cuts to Medicare Coverage
“Congress must stop these double-digit, devastating cuts to independent Medicare doctors and their patients to ensure all Americans receive affordable, quality healthcare,” said Bob Still, Executive Director of the RBM…
Reach Healthcare Debuts ‘Beyond the Ordinary’ Immersive Technology Experience at HLTH 2022
SAN DIEGO – November 3, 2022 – (Newswire.com)
Reach Healthcare will debut a three-part exhibition at HLTH 2022 entitled “Beyond the Ordinary.” It will showcase three multi-sensory immersive solutions for transforming health and well-being care and take attendees on a three-part experiential journey that explores new modalities for addressing: workforce wellness and clinician burnout; improving maternal-infant health outcomes; and boosting post-operative and transitional recovery, rehabilitation and chronic healthcare management.
Reach Healthcare experiences will be centrally located in the Bassano Rooms (#2602, 2603 and 2604) during HLTH 2022, which runs Nov 13 through 16 at the Venetian Expo and Convention Center in Las Vegas NV.
“What if we focused more on sensory elements in health centers, birth centers, diagnostic centers, nursing homes, rehabilitation centers…even hospital-at-home and retail health?” Reach’s President, Fran Ayalasomayajula, asks. The Reach sensory solutions go beyond tossing a plant in a corner or drowning out spaces with white noise.
“For centuries research has shown the power of sensory stimulation to heal, revive, and restore,” Reach’s President, Fran Ayalasomayajula, points out. At HLTH, Reach will present a walking gallery experience infused with elements that stimulate the senses, through the application of transformational and immersive sound and music, visual effects and imagery, textures, smells and tactile interaction.
This first-time offering at HLTH will showcase ways technology can be used to harness positive, calming, healing, and restorative experiences. It will serve as a departure from traditional approaches.
“HLTH is pleased to have Reach Healthcare host their breakthrough immersive therapeutic approach to health and wellbeing at this year’s event. This is an important area of focus for HLTH and aligns perfectly with our recently launched brand – WELL by HLTH,” said Rich Scarfo, President of HLTH.
Reach Healthcare’s mission is to provide a platform that delivers groundbreaking solutions to improve and transform healthcare delivery and outcomes for providers and patients, as well as to offer cost-effective solutions for payers.
THE SCIENCE OF HEALING and WELLNESS: BENEFITS OF MULTISENSORY EXPERIENCES
Reach Healthcare’s “Beyond the Ordinary” experiences at HLTH are built on three relevant scientific findings:
- Healthcare Settings Matter. In a 2020 Clinical Empathy study that Reach commissioned with Ipsos, a key finding was that environments matter. Patients seek supportive and familiar environments, and they also place a high value on milestones and memories associated with their environments.
Healthcare Settings directly affect the patient’s overall health and well-being, since they also impact relationships, including those of care teams and healthcare consumers. Reach Healthcare solutions enable care facilities, especially hospitals and healthcare providers, to deliver a less stressful experience and minimize the upset and friction between the patient with their providers.
- Sounds and Music Matter. Additional research by Reach revealed that listening to certain sounds and music can reduce anxiety and pain, blood pressure and heart rate, improve sleep quality, mood, mental alertness and memory — and shorten the length of hospital stays. The layering of digital multimedia and cinematography also delivers similar positive health outcomes.
- Sounds are not limited to the patient journey – but also extend to the provider. The Aesthetic Surgery Journal reported that researchers from the University of Texas Medical Branch at Galveston found that plastic surgeons closed incisions better and faster when done — while listening to their preferred music.
OTHER COLLABORATIONS
“Beyond the Ordinary” presented by REACH comes to life with the engagement of Reach’s technology partners, including HARMAN Digital Transformation Solutions (DTS). REACH’s Happy Mama, a maternity app and decision support tool for maternal health professionals, is powered by the HARMAN Remote Care Platform (RCP). Happy Mama will be on display as part of the activation
HARMAN International is a wholly-owned subsidiary of Samsung Electronics Co., Ltd. that is focused on connected technologies for automotive, consumer and enterprise markets.
This collaboration with visual effects powered by Samsung Digital Display Division joins others within the Reach orbit. They include: Birth & Life Photography and MovingArt by Louis Schwartzberg, as seen on Oprah (OWN), Netflix, and Reach Live.
Other contributors to the “Beyond the Ordinary” presented by Reach include OddBall, HealthTunes, Spatial Inc., and Visual Health Solutions.
Reach Healthcare’s “Beyond the Ordinary Experience” at HLTH 2022 “takes the attendee on a holistic therapeutic journey through the art and science of healing and wellness — with the help of immersive multisensory technologies that deliver solutions from a ‘people-first’ perspective to transform everyday lives,” concludes Reach’s President, Fran Ayalasomayajula.
ABOUT HLTH 2022:
HLTH (pronounced “health”) is the leading platform bringing together the entire health ecosystem, focused on health innovation and transformation. From unparalleled events with industry-leading speakers to inspirational digital content and mission-driven initiatives, HLTH creates a unique marketplace for the health community leading the dialogue and development of a better health ecosystem. Our mission is to gather the health community in curated, purposeful engagements that accelerate healthcare innovation.
Event Registration: https://www.hlth.com/2022event
Media – Special Exhibition Tours: https://www.hlth.com/2022event/media
#hlth2022
ABOUT REACH
REACH is a 501c3 global innovative social impact organization whose mission is to improve and transform healthcare delivery and outcomes for providers and patients, as well as to offer cost-effective solutions for payers.
Maternal mortality and morbidity prevention is a top priority area for the organization. Reach is the founder of the National Save Moms Campaign (http://savemoms.us), Save Moms Global (http://savemoms.global), Maternal Application of Technology for Community Health (MATCH) Coalition (http://matchcoalition.us), and Happy Mama (http://happymama.global).
Reach, established in 2016, is focused on pragmatically improving large-scale and sustainable health programs for enhanced healthcare equity, access, and delivery based on its four pillars: (1) Research to identify where change is needed that could result in actionable outcomes; (2) Education; (3) Thought Leadership and (4) Innovative Immersive Special Interest Therapeutic Platforms, including Happy Mama, focused on maternal health for mothers as well as clinicians; Workforce Wellness to tackle clinician burnout; and IB Healthy Wellness and Remote Care digital therapeutics for rehab, chronic disease management, healthy aging, and more.
Reach welcomes new partnerships, sponsorships, and grassroots affiliates as it works to drive massive impact for better and more equitable healthcare outcomes.
Contact Information:
Matt Walker
Community Outreach Lead
619-800-6443
Press Release Service
by
Newswire.com
Original Source:
Reach Healthcare Debuts ‘Beyond the Ordinary’ Immersive Technology Experience at HLTH 2022